About Our Lab
The lab of Dr. Marcus E. Peter studies various forms of cell death including apoptosis, which is a fundamental process to regulate homeostasis of all tissues and to eliminate unwanted cells specifically in the immune system. Another interest lies in the study of RNA interference and based on toxic RNAs to development a novel form of cancer treatment. The laboratory is located within the Robert H. Lurie Cancer Center at Northwestern University.
Trinucleotide repeat disorders like Huntington's disease show severe neurological pathologies, but are also characterised by reduced cancer susceptibility. A new study from the PeterLab demonstrates that siRNAs based on trinucleotide repeats show specific toxicity against cancer cells, explaining the low cancer incidence in triple repeat diseases.
The interview with Dr Peter starts at minute 30:56
Small RNA molecules can trigger a mechanism hidden in every cell, forcing it to commit suicide, according to a new Northwestern Medicine study, the first to identify molecules that trigger such a fail-safe mechanism.
Click here to read the press release.
Click here to listen to the interview.
In August 2015, Dr. Peter was selected as an inaugural recipient of the NCI R35 Outstanding Investigator Award (OIA), which provides seven years of research support to investigators with outstanding records of productivity and achievement in cancer research
A postdoctoral position is available in the laboratory of Dr. Marcus Peter to study the role of toxic RNAs to kill cancer cells as described in eLife 6, e29702, 2017.
Successful candidates should be highly motivated and have a recent Ph.D. degree with strong background in molecular biology and/or cell biology. Experience in working with protein and RNA methods is required. Experience in working with mice would be desired but is not mandatory.
Interested individuals should send a C.V. and names of three references to the address below or by email:
Feinberg School of Medicine
303 E Superior St, Lurie 6-123
Chicago, Il 60611